Last reviewed · How we verify
NCT05156138
The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
trial testing no interventions as it is a case control observational study in Pseudoexfoliation Syndrome in 50 participants. Status unknown.
24 July 2022
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 24 January 2022 |
| Primary completion | 24 July 2022 |
| Estimated completion | 24 September 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- no interventions as it is a case control observational study
Conditions studied
- Pseudoexfoliation Syndrome — all drugs for Pseudoexfoliation Syndrome →
Sponsor
Assiut University
Who can join
50 and older, any sex, with Pseudoexfoliation Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to compare the endothelial cell count in patients with pseudoexfoliation syndrome to the the endothelial cell count in normal patients above the age of 50.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05156138
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pseudoexfoliation Syndrome
Currently open trials in the same condition.
- NCT07506551 — Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome · NA · active not recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05156138 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 14 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05156138.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing